Skip to content

The efficacy of single-dose aescin in preventing postoperative sore throat compared to placebos: a double-blinded, randomized controlled trial

The efficacy of single-dose aescin in preventing postoperative sore throat compared to placebos: a double-blinded, randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190903005
Enrollment
308
Registered
2019-09-03
Start date
2019-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who are undergoing surgery with general anesthesia ASA physical status I and II aescin postoperative sore throat incidence

Interventions

placebo tablet that resembles the experimental one,Aescin extract is commercially sold in tablets with Trade name Reparil. The patient in experimental group will take Reparil 2 tabs within 2 hours bef
Placebo Comparator Drug,Experimental Drug
placebo,Aescin

Sponsors

HRH Princess Maha Chakri Sirindhorn Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Age > 18-64 years. American Society of Anesthesiologists physical status I-II Elective gynecologic surgery, abdominal surgery, breast surgery, orthopedic surgery Supine surgical position and neutral neck position Operation time more than 1 hour and less than 6 hours

Exclusion criteria

Exclusion criteria: Known hypersensitivity to aescin and any drugs in this study Glucose, galactose, fructose intolerance Renal insufficiency/renal failure or kidney diseases Pregnancy Preoperative sore throat History of upper respiratory tract illness Pre-existing pulmonary disease History of psychiatric disorders History of difficult intubation/suspected difficult airway Excessive external laryngeal manipulation Insert any equipment to oral cavity ex. Panendoscopy, ERCP, EGD, dilate esophagus, NG or OG insertion, nasal temperature probe Patients who are already intubated before general anesthesia

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative sore throat up to 24 hours post operative incidence comparison

Secondary

MeasureTime frame
severity of postoperative sore throat up to 24 hours mean comparison,speed of recovery from postop sore throat within 24 hours postop log-rank test

Countries

Thailand

Contacts

Public ContactChaiyapruk Kusumaphanyo

Srinakharinwirot university

chaiyapruk@gmail.com037395085

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026